| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8790027 | Urologic Oncology: Seminars and Original Investigations | 2018 | 11 Pages | 
Abstract
												There was no difference between minority-serving and nonminority-serving hospitals in overall survival or receipt of definitive treatment. Black patients suffered worse survival and were less likely to receive definitive treatment for bladder cancer regardless of the type of hospital in which they were treated.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Sean A. B.S., Philipp M.D., Alexander P. M.D., Malte W. M.D., Adam S. M.D., Toni K. M.D., Guru P. M.D., Mark A. M.D., M.P.H., Daniel M.D., Mani M.D., Maxine Ph.D., M.P.H., Stuart R. Sc.D., Quoc-Dien M.D., 
											